MiMedx Group, Inc. (MDXG)
3.91
-0.02
(-0.51%)
USD |
NASDAQ |
Oct 23, 16:00
3.905
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Market Cap : 569.78M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 569.78M |
| October 22, 2026 | 572.70M |
| October 21, 2026 | 545.01M |
| October 20, 2026 | 616.41M |
| October 19, 2026 | 638.27M |
| October 16, 2026 | 645.56M |
| October 15, 2026 | 681.99M |
| October 14, 2026 | 684.90M |
| October 13, 2026 | 683.45M |
| October 12, 2026 | 703.85M |
| October 09, 2026 | 680.53M |
| October 08, 2026 | 673.25M |
| October 07, 2026 | 671.79M |
| October 06, 2026 | 673.25M |
| October 05, 2026 | 663.05M |
| October 02, 2026 | 668.88M |
| October 01, 2026 | 676.16M |
| September 30, 2026 | 679.08M |
| September 29, 2026 | 680.53M |
| September 28, 2026 | 681.99M |
| September 25, 2026 | 680.53M |
| September 24, 2026 | 686.36M |
| September 23, 2026 | 695.11M |
| September 22, 2026 | 718.42M |
| September 21, 2026 | 700.93M |
| Date | Value |
|---|---|
| September 18, 2026 | 695.11M |
| September 17, 2026 | 683.45M |
| September 16, 2026 | 689.28M |
| September 15, 2026 | 687.82M |
| September 14, 2026 | 676.16M |
| September 11, 2026 | 665.96M |
| September 10, 2026 | 670.33M |
| September 09, 2026 | 681.99M |
| September 08, 2026 | 680.53M |
| September 04, 2026 | 665.96M |
| September 03, 2026 | 645.56M |
| September 02, 2026 | 663.05M |
| September 01, 2026 | 658.67M |
| August 31, 2026 | 661.59M |
| August 28, 2026 | 655.76M |
| August 27, 2026 | 657.22M |
| August 26, 2026 | 644.10M |
| August 25, 2026 | 632.44M |
| August 24, 2026 | 622.24M |
| August 21, 2026 | 630.99M |
| August 20, 2026 | 626.61M |
| August 19, 2026 | 648.47M |
| August 18, 2026 | 632.44M |
| August 17, 2026 | 610.59M |
| August 14, 2026 | 622.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 286.66M |
| Perspective Therapeutics, Inc. | 183.68M |
| ABVC BioPharma, Inc. | 26.80M |
| Enovis Corp. | 1.216B |
| Edwards Lifesciences Corp. | 51.36B |
Market Cap Related Metrics
| PE Ratio | 98.99 |
| PS Ratio | 1.641 |
| Price to Book Value | 2.638 |
| Price to Free Cash Flow | 13.77 |
| Price | 3.91 |
| Earnings Yield | 1.01% |
| Operating PE Ratio | 66.58 |
| Normalized PE Ratio | 99.24 |